| Bid price | 28.00 | Open price | 29.00 |
|---|---|---|---|
| Ask price | 30.00 | Prev close | 29.00 |
| High price | 28.50 | Spread | 6.67% |
| Low price | 28.10 | Volume | 47,200 |
Register now for FREE live Tristel share prices, Tristel stock quotes, charts, trades and FREE Tristel company fundamentals, market news and much much more. Why not upgrade to a premium service and get Tristel Level 2 Data, indepth research tools and investor commentary for Tristel (TSTL) and other London Stock Exchange equities.
Register now for FREE Tristel share price charts
| Name | Tristel | Epic | TSTL |
|---|---|---|---|
| Activites | Designs, manufactures and sells infection control and water treatment products | Reuters | TSTL.L |
| ISIN | GB00B07RVT99 | Google Finance | LON:TSTL |
| Share Price (p) | 29.00 | Prev. Share Price (p) | 29.00 |
|---|---|---|---|
| Shares in Issue (m) | 40 | Market Cap (£m) | 12 |
| PE Ratio (x) | 37.40 | Div per share (p) | 0.10 |
| Div yield (%) | 1.22 | Div cover (x) | 0.75 |
| EPS (p) | 1.30 | PEG | -4.26 |
Register now for FREE Tristel company fundamentals
| Dec.Date | Type | Director | Pos | No. of Shares |
|---|---|---|---|---|
| 30/04/2012 | BUY | Francisco Soler | CH | 150,000 |
| 30/04/2012 | SELL | Peter Stephens | NED | 150,000 |
| 04/01/2012 | BUY | Francisco Soler | CH | 527,400 |
| 23/12/2011 | SELL | Paul Swinney | CEO | 80,000 |
| 23/12/2011 | BUY | Francisco Soler | CH | 80,000 |
Francisco Soler, Chairman, bought 150,000 shares in the company on the 27th April 2012 at a price of 33.00p. The Director now holds 8,698,877 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
Peter Stephens, Non Executive Director, sold 150,000 shares in the company on the 27th April 2012 at a price of 32.90p. The Director now holds 778,521 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
/* */ RNS Number : 2902C Tristel PLC 30 April 2012 TRISTEL plc Directors' Shareholdings Tristel plc ("Tristel" or the "Company"), the manufacturer of infection control, contamination control and hygiene products, announces that the Company has...
Register now for FREE Tristel company news
At a time of out-of control MRSA and other Diarrhoea bugs that are swamping our hospitals, Tristel which sells its bacteria destroying products to over 60% of all NHS hospitals, could be a little gem to add to your portfolio. Already a profitable company and with several patents and new products...
Register now for FREE Tristel share price discussions